medigraphic.com
ISSN 1025-0298 (Electronic)
ISSN 1025-028X (Print)

2021, Number 3

<< Back Next >>

VacciMonitor 2021; 30 (3)

Association of IL-1β +3954 G>A and IL-6 -174 G/C polymorphisms in congenital toxoplasmosis

Mousa NM, Jasim HM

Language: English
References: 23
Page: 125-132
PDF size: 396.76 Kb.


ABSTRACT

Toxoplasmosis is caused by infection with the protozoan parasite Toxoplasma gondii, that has the capacity to infect all warm-blooded animals worldwide. The purpose of this investigation was to determine the distribution of genotypes and alleles in miscarriages woman as a result of Toxoplasma gondii infection associated with interleukin-1β and interleukin-6 polymorphisms. A total of 125 miscarriage women suspected of toxoplasma infection and 50 healthy pregnant without previous miscarriage as control were enrolled in this study. The cases were screened for anti-toxoplasma IgM and IgG by ELISA test. Among the 125 miscarriage women, only 50 were positive to anti-Toxoplasma gondii IgG and IgM antibodies. The present study focused on assay the genotypes at IL-6 -174 G/C and IL-1β +3954 G>A to establish the associations between genetic polymorphisms and infection with Toxoplasma gondii. Results showed that the altered IL-1β GA, AA genotypes were high significant elevated in miscarriage women with toxoplasmosis (P=0.03), OR = 10 and 95% confidence intervals (1.32-81.48); (P=0.0007), OR = 0.07 and 95% confidence interval (0.01-0.32). The genotype GC at IL-6 (G/C) appears to be highly correlated with infection (P=0.01); OR = 3.18 and 95% confidence interval, (1.22- 8.30). In terms of allelic heterogeneity, C alleles were significantly more common in infected than uninfected cases for IL-6, while A allele is common in IL-1β single nucleotide polymorphisms (P =0.050). Furthermore, this study demonstrates that there is a strong and highly significant association between two forms of single nucleotide polymorphisms and the increased risk for toxoplasmosis. Genotypes of these polymorphism should be considered when evaluating genetic effects on toxoplasmosis incidence. However, to improve the prediction of this disease predisposition, a further study based on a larger cohort of patients is warranted.


REFERENCES

  1. Gross CP, Sepkowitz KA. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered. Int J Infect Dis. 1998; 3(1):54-60. doi: https://10.1016/S1201-9712(98)900960.

  2. Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: WB Saunders; 2004.p.1-15.

  3. Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011; 12(6):509-17. doi: https://10.1038/ni.2039.

  4. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect. 1984; 8(1):13-21. doi: https://10.1016/s0163-4453(84)93192-x.

  5. World Health Organization. The Global Vaccine Action plan (GVAP). 2019. Geneva: World Health Organization; 2019. Available at: https://www.who.int/immunization/sage/meetings/2019/october/5_GVAP_2019_Regional_reports_YB.PDF. (Consulted in December 06 2020).

  6. United Nations Children's Fund (UNICEF). Immunization program 2019. New York: UNICEF; 2019. (Consulted on December 06 2020). Available at: https://www.unicef.org/immunization.

  7. Worldometer. Pakistan Population (Live). 2020. Available from: https://www.worldometers.info/world-population/pakistan-population/. (Consulted on December 06 2020).

  8. World Health Organization. Expanded Programme on immunization, Pakistan. Washington DC: World Health Organization; 2020. Available at: http://www.emro.who.int/pak/programmes/expanded-programme-on-immunization.html. (Consulted on December 06 2020).

  9. Kabir M, Afzal MS. Epidemiology of polio virus infection in Pakistan and possible risk factors for its transmission. Asian Pac J Trop Med. 2016;9(11):1044-7. doi: https://10.1016/j.apjtm.2016.09.006.

  10. End polio pakistan: Pakistan Polio Eradication Programme. Polio Cases in Provinces 2021. Islamabad: Government of Pakistan; 2021. Available at: https://www.endpolio.com.pk/polioin-pakistan/polio-cases-in-provinces. (Consulted on April 25 2021).

  11. Kanwal S, Kanwal S, Kousar A, Basit A. Coverage of Tetanus Toxoid and Rubella Vaccination Among Female Students of Qamc and Iub, Bahawalpur. Indo Amer J Pharma Sci. 2018; 5(5):3499-514. doi: https://10.5281/zenodo.1243148.

  12. Riaz A, Husain S, Yousafzai MT, Nisar I, Shaheen F, Mahesar W, et al. Reasons for non-vaccination and incomplete vaccinations among children in Pakistan. Vaccine. 2018; 36(35):5288-93. doi: https://10.1016/j.vaccine.2018.07.024.

  13. William GC. Sampling Techniques. New York: John Wiley & Sons;1977.

  14. Cvjetkovic SJ, Jeremic VL, Tiosavljevic DV. Knowledge and attitudes toward vaccination: A survey of Serbian students. J Infect Public Health. 2017; 10(5):649-56. doi:https://10.1016/j.jiph.2017.05.008.

  15. Khan MT, Zaheer S, Shafique K. Maternal education, empowerment, economic status and child polio vaccination uptake in Pakistan: a population based cross sectional study. BMJ open. 2017;7(3):e013853. doi: https://10.1136/bmjopen-2016- 013853.

  16. Kazi AM, Ahsan N, Khan A, Jamal S, Kalimuddin H, Ghulamhussain N, et al. Personalized text messages and automated calls for improving vaccine coverage among children in Pakistan: Protocol for a community-based cluster randomized clinical trial. JMIR Res Protoc. 2019;8(5):e12851. doi: https://10.2196/12851.

  17. Shafiq Y, Khowaja AR, Yousafzai MT, Ali SA, Zaidi A, Saleem AF. Knowledge, attitudes and practices related to tetanus toxoid vaccination in women of childbearing age: A cross-sectional study in peri-urban settlements of Karachi, Pakistan. J Infect Prev. 2017; 18(5):232-41. doi: https://10.1177/1757177416689722.

  18. Siddiqi N, Khan A, Nisar N, Siddiqi A. Assessment of EPI (expanded program of immunization) vaccine coverage in a peri-urban area. J Pak Med Assoc. 2007; 57(8):391-5.

  19. Farrukh MJ, Ming LC, Zaidi ST, Khan TM. Barriers and strategies to improve influenza vaccination in Pakistan. J Infect Public Health. 2017; 10(6):881-3. doi: https://10.1016/j.jiph.2016.11.021.

  20. Riaz A, Husain S, Yousafzai MT, Nisar I, Shaheen F, Mahesar W, Dal SM, Omer SB, Zaidi S, Ali A. Reasons for non-vaccination and incomplete vaccinations among children in Pakistan. Vaccine. 2018; 36(35):5288-93. doi: https://10.1016/j.jiph.2016.11.021.

  21. Antai D. Inequitable childhood immunization uptake in Nigeria: A multilevel analysis of individual and contextual determinants. BMC Infect Dis.2009;9:181. doi: https://10.1186/1471-2334-9-181.

  22. Abdulraheem IS, Onajole AT, Jimoh AA, Oladipo AR. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. J Public Health Epidemiol. 2011;3(4):194-203.

  23. Naeem M, Imtiaz A, Hussain H, Hidayat S. Barriers in immunization of children under two years of age in Mohmand Agency, Federally Administered Tribal Area, Pakistan. J Saidu Med Coll. 2018;8(2):75-82. Available at: https://jsmc.pk/index.php/jsmc/issue/archive.




2020     |     www.medigraphic.com